Perioperative TORIPALIMAB Plus LENVATINIB in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PLUTO)
Clinical trial NCT06114940 · TERMINATED
Trial details
- NCT number
- NCT06114940
- Sponsor
- Jinling Hospital, China
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-20
- Primary completion
- 2026-01-10
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.